Yutaka Matsuda
Director, ADC Chemistry Exelixis, Inc.
Seminars
Thursday 6th November 2025
Workshop highlights include:
- Discussing the growing need for novel ADC payloads in the face of ADC patient resistance mechanisms
- Weighing up the pros and cons of catalytic and immune-stimulating payloads safety and efficacyÂ
- Assessing MoA characterization of ADC payloads beyond classical cytotoxic agentsÂ
